Skip to main content

Schizophrenia

Center of Excellence

Leaders in the field sharing authoritative insights and institutional best practices
Q&A
Researcher Christian Hakulinen, PhD, shares details of a study which found that higher amounts of time spent in a low-income environment during childhood were associated with increased risk of schizophrenia after age 15.
Q&A
Sophia Frangou, MD, PhD, FRCPsych, discusses a study that suggests people with schizophrenia develop the vulnerability to hear “voices” years before the onset of symptoms.
Q&A
Researcher Michael Birnbaum, MD, discusses a recent study which found significant trends in the Facebook activity of young people in the month before the onset of psychosis.
Q&A
Brian Kirkpatrick, MD, and Gary Hack, DDS, discuss a recently published study examining palate width in subgroups of people with schizophrenia.
PRESENTATION
SAN FRANCISCO—Panels of speakers at 2 American Psychiatric Association (APA) Annual Meeting sessions encouraged clinicians to consider prescribing clozapine in patients with treatment-refractory schizophrenia, despite the many challenges which come with using the drug.
BLOG
BLOG: A recent experience showed me that seeing tardive dyskinesia (TD) can be hard, even for people who have made a commitment to look for it.
INTERVIEW
Anticipate some significant changes in the treatment of schizophrenia over the next 10 years, from a move toward coordinated specialty care to harnessing the power of social media to help identify symptoms sooner, said John M. Kane, MD.
YOUR QUESTIONS ANSWERED
Is there any rationale for using both deutetrabenazine (Austedo) and valbenazine (Ingrezza) at the same time? Find out from Psych Congress cochair Rakesh Jain, MD, MPH.
YOUR QUESTIONS ANSWERED
Is there benefit in treating a patient with a VMAT2 inhibitor if they have already had severe tardive dyskinesia for several years? Find out here.
YOUR QUESTIONS ANSWERED
Are medications for tardive dyskinesia effective in mild, moderate, or severe cases? Get the answer from Psych Congress cochair Rakesh Jain, MD, MPH.
Back to Top